Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.

作者: Elisabetta Trino , Cristina Mantovani , Serena Badellino , Umberto Ricardi , Andrea Riccardo Filippi

DOI: 10.1080/14737140.2017.1296764

关键词:

摘要: ABSTRACTIntroduction: The clinical landscape of advanced melanoma drastically changed after the introduction both targeted therapies and immunotherapy. This rapid development in systemic led to a change management patients with brain metastases, subsequent need re-assess role local therapies, particular stereotactic radiosurgery (SRS).Areas covered: In this non-systematic review, we report on current knowledge use SRS combination immunotherapy BRAF/MEK inhibitors for as well ongoing trials field.Expert commentary: It is now more common observe metastases better performance status prolonged life expectancy. A therapy immunotherapy, different sequences, has been shown be feasible tolerable, basis retrospective reports. Additional data from prospective are however needed confir...

参考文章(84)
Dirk Schadendorf, Sangeetha Ramanujam, Georgina V. Long, Systemic therapies for melanoma brain metastases: which drug for whom and when? Chinese clinical oncology. ,vol. 4, pp. 25- ,(2015) , 10.3978/J.ISSN.2304-3865.2015.06.06
Klaus K. Herfarth, Oxana Izwekowa, Christoph Thilmann, Andrea Pirzkall, Stefan Delorme, Udo Hofmann, Dirk Schadendorf, Dietmar Zierhut, Michael Wannenmacher, Jürgen Debus, Linac-Based Radiosurgery of Cerebral Melanoma Metastases Strahlentherapie Und Onkologie. ,vol. 179, pp. 366- 371 ,(2003) , 10.1007/S00066-003-1050-Z
Masaaki Yamamoto, Takuya Kawabe, Yasunori Sato, Yoshinori Higuchi, Tadashi Nariai, Shinya Watanabe, Hidetoshi Kasuya, Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors. Journal of Neurosurgery. ,vol. 121, pp. 16- 25 ,(2014) , 10.3171/2014.8.GKS141421
Kazuhiro Yamanaka, Toshiya Tachibana, Tokuhide Moriyama, Fumiaki Okada, Keishi Maruo, Shinichi Inoue, Yutaka Horinouchi, Shinichi Yoshiya, C-5 palsy after cervical laminoplasty with instrumented posterior fusion Journal of Neurosurgery. ,vol. 20, pp. 1- 4 ,(2014) , 10.3171/2013.9.SPINE12952
Donald N. Liew, Hideyuki Kano, Douglas Kondziolka, David Mathieu, Ajay Niranjan, John C. Flickinger, John M. Kirkwood, Ahmad Tarhini, Stergios Moschos, L. Dade Lunsford, Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. Journal of Neurosurgery. ,vol. 114, pp. 769- 779 ,(2011) , 10.3171/2010.5.JNS1014
Bianca Devitt, Wendy Liu, Renato Salemi, Rory Wolfe, John Kelly, Chin-Yuan Tzen, Alexander Dobrovic, Grant McArthur, Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma Pigment Cell & Melanoma Research. ,vol. 24, pp. 666- 672 ,(2011) , 10.1111/J.1755-148X.2011.00873.X
Y. Ishida, Y. Agata, K. Shibahara, T. Honjo, Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. The EMBO Journal. ,vol. 11, pp. 3887- 3895 ,(1992) , 10.1002/J.1460-2075.1992.TB05481.X
Andrew E. Radbill, John F. Fiveash, Elizabeth T. Falkenberg, Barton L. Guthrie, Paul E. Young, Sreelatha Meleth, James M. Markert, Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer. ,vol. 101, pp. 825- 833 ,(2004) , 10.1002/CNCR.20447
Marcin Kowanetz, Daniel S. Chen, F. Stephen Hodi, Omid Hamid, Jeffrey Alan Sosman, Donald P. Lawrence, Ryan J. Sullivan, Nageatte Ibrahim, Harriet M. Kluger, Peter D. Boasberg, Keith Flaherty, Patrick Hwu, Marcus Ballinger, Ahmad Mokatrin, Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with locally advanced or metastatic melanoma (mM). Journal of Clinical Oncology. ,vol. 31, pp. 9010- 9010 ,(2013) , 10.1200/JCO.2013.31.15_SUPPL.9010
Jonathan P. S. Knisely, James B. Yu, Jaclyn Flanigan, Mario Sznol, Harriet M. Kluger, Veronica L. S. Chiang, Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival Journal of Neurosurgery. ,vol. 117, pp. 227- 233 ,(2012) , 10.3171/2012.5.JNS111929